We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03552276
Brief Title: Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

First Submitted : May 4, 2018
First Submitted that Met QC Criteria : June 8, 2018
First Posted : June 11, 2018

Last Update Submitted that Met QC Criteria : August 26, 2022
Last Update Posted : August 29, 2022